Authors


Thomas R. Insel, MD

Latest:

Federal Court Gives Green Light to Deny Coverage

"With our country’s ongoing mental health and addiction crisis, the consequences of the Wit v UBH reversal are too great to ignore."


Thomas R. Kosten, MD

Latest:

Exploring Genetic Models in Schizophrenia Research: A Teaser From ACNP Annual Meeting

Thomas R. Kosten, MD, shares thoughts on the latest schizophrenia genetic model research presented at the meeting.


Thomas R. Linden, MD

Latest:

Marketing Off-Label Uses: Shady Practices Within a Gray Market

For pharmaceutical companies, off-label use of a drug represents a substantial “gray market,” to which the company is unable to sell their product directly, yet may be a significant revenue stream. Some drugs have been used more for off-label purposes than for originally approved indications.1


Thomas S. May

Latest:

Diagnosing Dementia: Essential for Prognosis, Treatment, and Potential Cure

Defined as a clinical syndrome involving progressive deterioration in multiple areas of cognitive functioning, dementia is a major cause of disability, institutionalization, and increased mortality among the elderly. Although it can occur in younger persons too, dementia is typically associated with aging. It is often seen as a disease that cannot be prevented or cured. However, there is increasing evidence that some types of dementia can be successfully treated or even reversed.


Thomas W. Heinrich, MD

Latest:

Hypothyroidism: An Important Diagnostic Consideration for the Psychiatrist

Hypothyroidism is a common clinical disorder that psychiatrists frequently encounter. However, symptoms of thyroid dysfunction are often vague and nonspecific, which can lead to delayed or missed diagnosis.


Tiffany Floyd, PhD

Latest:

Group Therapy and Cancer Survival-- Where Does the Evidence Lie in 2007?

One of the most hotly debated questions within oncology over the past decade has been whether the promotion of psychological wellness can extend survival for patients with advanced cancer. The converse--that psychiatric disorder shortens survival--seems true, with mechanisms of poor self-care and reduced adherence to anticancer treatments resultant from depressive or psychotic disorders explaining this outcome.


Tiffany N. Andry, MD

Latest:

Emerging Treatments and Pharmacogenetics for Cocaine Use Disorder

There are no FDA-approved pharmacotherapies for cocaine use disorder. Here: a review of the off-label use of promising medications for this addiction.


Tiffini Voss, MD

Latest:

Managing the Psychiatric Manifestations of Parkinson Disease: An Update

Parkinson disease (PD) is a progressive neurodegenerative disorder affecting 1% of people 65 years and older. The core symptoms include the motor manifestations of tremor, bradykinesia, and rigidity.


Tim Outhred, PhD

Latest:

Lithium Therapy, Bipolar Disorder- and Neurocognition

Functional mood stability can be attained with lithium therapy, but guidelines on how to get there have become increasingly sophisticated.


Tim Phillips

Latest:

Why Are Young Westerners Drawn to Terrorist Organizations Like ISIS?

The authors explore possible reasons why young people in the West leave their families, friends, and home culture to join terrorist organizations.


Timothy D. Brewerton, MD

Latest:

The Links Between PTSD and Eating Disorders

Despite an abundance of studies linking both traumatic experiences and anxiety disorders with eating disorders, relatively little has been reported on the prevalence of associated posttraumatic stress disorder (PTSD) or partial PTSD in patients with eating disorders.


Timothy G. Lesaca, MD

Latest:

On Leadership and Holding the Lantern

In this incredible era of breakthroughs in neuroscience and its applied therapies, psychiatrists have been recognized as leaders and pioneers in battling the previously elusive maladies of the human condition. In the darkness, people instinctively follow the person carrying the lantern. As a consequence, I am not necessarily sure where we're going.


Timothy J. Peters, MD, PhD

Latest:

Bedlam: London and Its Mad

As expected from an Oxbridge graduate, author Catharine Arnold’s Bedlam: London and Its Mad is a well-written and very readable book. “This book is for all whose lives are touched by madness” is a laudable objective.


Timothy Lesaca, MD

Latest:

Preadoption Risk Factors

Although adoption dates back centuries, the issue of whether or not adopted children are at risk for psychological maladjustment remains controversial. That this dispute would occur at all is not surprising, since as recently as 1926 laws which liberalized adoptions in England were faced with a widespread objection that adoption would encourage depraved conduct.



Timothy P. Condon, PhD

Latest:

Prevention and Treatment of Addiction

In 2006, substance dependence or abuse was diagnosed in about 22.6 million persons in the United States.1 Addiction-related morbidity and mortality pose a major burden to society, costing our economy more than $500 billion annually: about $181 billion for illicit drugs,2 $168 billion for tobacco,3 and $185 billion for alcohol.4


Timothy S. Carey, MD, MPH

Latest:

Marketing Off-Label Uses: Shady Practices Within a Gray Market

For pharmaceutical companies, off-label use of a drug represents a substantial “gray market,” to which the company is unable to sell their product directly, yet may be a significant revenue stream. Some drugs have been used more for off-label purposes than for originally approved indications.1


Timothy W. Fong, MD

Latest:

Addressing Myths and Facts About Cannabis Use

Timothy W. Fong, MD, touches on our current understanding about cannabis use for psychiatric disorders.


Timothy Wilens, MD

Latest:

Substance Use Among Adolescents and Young Adults

In this CME, check out best practices for screening and treating adolescents and young adults with substance use issues.


Tina Beychok

Latest:

News Brief: ICU Staff May Suffer From Psychiatric Difficulties

Caregivers in high-pressure medical settings, such as intenstive care units (ICUs), can suffer from high levels of stress, resulting in emotional exhaustion, diminished empathy for patients, and decreased productivity.


Tish Conwell

Latest:

Psychiatric Conditions Affecting Physicians With Disruptive Behavior

This study highlights the need to consider a holistic approach when discussing the problem of disruptive behavior in health care settings.


Tobias Wasser, MD

Latest:

Impacting Policies, Practices, and Other Physicians

Do you need to build leadership skills? Check out this 2024 APA Annual Meeting session from the American Association for Psychiatric Administration and Leadership!


Toby Measham, MD

Latest:

Taking Culture Into Account When Assessing a Young Patient

This list serves as a guide when treating persons of diverse cultures and backgrounds.


Todd A. Smitherman, PhD

Latest:

10 Salient Points About Migraine and Psychiatric Comorbidity

Where do migraines and psychiatric disorders intersect? Learn more.


Todd J. Farchione, PhD

Latest:

Development of a Transdiagnostic Unified Psychosocial Treatment for Emotional Disorders

Research emerging from the field of emotion science suggests that individuals who have anxiety and mood disorders tend to experience negative affect more frequently and more intensely than do healthy individuals, and they tend to view these experiences as more aversive, representing a common diathesis across anxiety and mood disorders.1-5 Deficits in the ability to regulate emotional experiences, resulting from unsuccessful efforts to avoid or dampen the intensity of uncomfortable emotions, have also been found across the emotional disorders and are a key target for therapeutic change.


Todd N. Schirmer, PhD

Latest:

Mobile Apps for Mental Health

Here: a look at Mobilyze and CrossCheck--2 apps currently in development that are embedded within smartphones and designed to capture objective data on patients to provide timely treatment and relapse prevention.


Tom Wooldridge, PsyD

Latest:

Macho, Bravado, and Eating Disorders in Men: Special Issues in Diagnosis and Treatment

Eating disorders are still thought of as a “female problem.” But 25% of those with anorexia and 36% of those with bulimia are males.


Tony Cohn, MD

Latest:

Metabolic Monitoring for Patients on Antipsychotic Medications

In this CME article, the focus is on the significance of metabolic changes that develop during antipsychotic treatment, as well as on strategies to incorporate metabolic monitoring into clinical practice.


Tony P. George, MD, FRCPC

Latest:

Using Brain Science to Develop Better, Safer, More Effective Treatments

Deep brain stimulation for substance use disorders when everything else fails, the history of the ACNP, and more.


Travis K. Svensson, MD

Latest:

Point

Prior to training in psychiatry, my practice was in a rural primary care setting where I routinely collaborated closely with physician assistants and nurse practitioners. I see prescriptive privileges of one form or another for psychologists to be an inevitability. I watched a similar struggle for nurse practitioner prescriptive privileges in Oklahoma during my stint in primary care. My recommendations to physicians in California would be to endorse prescriptive privileges for other mental health professionals in the format of the "physician extender" model similar to the traditional physician assistant.

© 2025 MJH Life Sciences

All rights reserved.